antisense oligonucleotide therapies

New progress presented at an annual conference of the American Heart Association signals renewed hope to repair the heart after injury.

A gene therapy trial halted after a child’s death, a CRISPR test to detect tuberculosis, a new device for antisense therapies, and more led the news this week.